本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Vor Biopharma Inc.

25.00
-0.5000-1.96%
盤後25.220.2188+0.88%19:56 EDT
成交量:20.40萬
成交額:509.34萬
市值:1.71億
市盈率:-0.07
高:25.56
開:25.16
低:24.59
收:25.50
52周最高:65.80
52周最低:2.62
股本:685.39萬
流通股本:317.51萬
量比:0.45
換手率:6.43%
股息:- -
股息率:- -
每股收益(TTM):-342.6591
每股收益(LYR):-34.0333
淨資產收益率:-125.43%
總資產收益率:-121.29%
市淨率:-0.11
市盈率(LYR):-0.73

資料載入中...

2025/07/15

關聯方擬減持公告

Form 144 | VOR BIOPHARMA INC.高管 Robert Ang 擬減持214135股,總價約52萬美元
2025/07/10

重要事件披露

Form 8-K - Current report
2025/07/10

關聯方擬減持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 擬減持596885股,總價約138.8萬美元
2025/07/03

關聯方擬減持公告

Form 144 | VOR BIOPHARMA高管 Robert Ang 擬減持44936股,總價約8.04萬美元
2025/07/01

關聯方擬減持公告

Form 144 | VOR BIOPHARMA高管Robert Ang擬減持40468股,總價約69613美元
2025/06/30

關聯方擬減持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 擬減持40627股,總價約70289美元
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/21

重要事件披露

Form 8-K - Current report
2025/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

重要事件披露

Form 8-K - Current report
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/28

SEC問詢函

Form CORRESP - Correspondence
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/28

SEC問詢函

Form CORRESP - Correspondence